Saturday 17 October 2026
Export WAT’s income statement to Excel — free account
Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
436.95
7.20
−1.62%
Follow WAT
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
35.20 | 34.48 | 30.18 | 29.24 | 33.06 | 29.49 | 26.40 | 24.37 | 815.38 | 21.09 |
Piotroski F-Score |
5 | 4 | 4 | 4 | 8 | 7 | 6 | 7 | 7 | 7 |
P/S ratio |
7.14 | 7.44 | 6.57 | 6.98 | 8.24 | 6.50 | 6.57 | 6.00 | 6.76 | 5.09 |
Altman Z-Score |
9.63 | 9.34 | 7.60 | 10.21 | 10.72 | 8.87 | 9.22 | 8.30 | 6.08 | 6.09 |
P/FCF ratio |
44.53 | 35.52 | 0.00 | 48.41 | 39.62 | 28.85 | 33.32 | 28.85 | 25.72 | 20.58 |
Altman Z″-Score (non-manufacturers) |
10.00 | 10.20 | 9.35 | 12.39 | 12.15 | 11.16 | 12.03 | 11.24 | 9.42 | 10.07 |
Beneish M-Score |
(2.37) | (2.49) | (2.22) | (2.19) | (2.53) | (2.88) | (2.56) | (2.21) | (3.04) | (2.61) |
P/Operating CF |
137.36 | 91.66 | 84.36 | 104.32 | 105.27 | 57.44 | 82.34 | 80.00 | 81.25 | 63.38 |
P/B ratio |
8.82 | 12.04 | 16.88 | 41.09 | 62.42 | 66.18 | 0.00 | 9.27 | 6.99 | 4.79 |
Price to Tangible BV |
34.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 15.06 | 9.49 | 6.32 |
EV/Sales |
7.25 | 7.88 | 7.21 | 7.33 | 8.57 | 6.82 | 7.08 | 5.76 | 6.11 | 4.57 |
EV/EBITDA |
22.76 | 22.90 | 21.68 | 21.69 | 25.06 | 20.92 | 20.95 | 16.43 | 18.38 | 13.74 |
EV/Operating CF |
35.19 | 30.59 | 35.37 | 35.60 | 31.97 | 20.40 | 26.50 | 23.06 | 20.24 | 15.41 |
EV/FCF |
45.24 | 37.62 | (25.38) | 50.85 | 41.26 | 30.28 | 35.94 | 27.69 | 23.25 | 18.50 |
Quick Ratio |
1.14 | 1.34 | 1.39 | 1.53 | 1.74 | 1.26 | 1.56 | 5.13 | 6.48 | 6.35 |
Current Ratio |
1.73 | 2.11 | 2.22 | 2.24 | 2.39 | 1.74 | 2.22 | 5.93 | 7.04 | 6.99 |
Net Debt/EBITDA |
0.36 | 1.28 | 1.94 | 1.04 | 0.99 | 0.99 | 1.53 | (0.69) | (1.95) | (1.54) |
Debt/Assets |
18.66% | 35.72% | 49.83% | 46.47% | 48.91% | 42.48% | 61.82% | 30.80% | 35.64% | 36.51% |
Debt/Equity |
0.37 | 0.89 | 2.00 | 3.02 | 4.12 | 5.20 | (7.31) | 0.73 | 0.85 | 0.74 |
Asset Turnover |
0.66 | 0.64 | 0.75 | 0.93 | 0.94 | 0.88 | 0.77 | 0.53 | 0.46 | 0.49 |
Operating CF/Net income |
1.02 | 1.19 | 0.94 | 0.86 | 1.08 | 1.52 | 1.09 | 1.02 | 34.35 | 1.23 |
Capex/Depreciation |
(0.70) | (0.74) | (8.70) | (1.41) | (1.28) | (2.02) | (1.56) | (0.89) | (0.85) | (0.94) |
Interest Coverage |
11.54 | 9.21 | 8.27 | 17.90 | 18.29 | 13.15 | 14.55 | 15.21 | 11.65 | 13.92 |
| 29.28% | 42.82% | 77.62% | 162.32% | 231.06% | 6,576.65% | 87.67% | 31.24% | 0.90% | 23.92% | |
| 13.35% | 13.90% | 16.24% | 22.20% | 23.35% | 19.33% | 18.85% | 13.12% | 0.41% | 11.68% | |
ROIC |
17.17% | 16.50% | 16.70% | 35.26% | 39.14% | 40.52% | 43.10% | 47.17% | 56.11% | 32.80% |
Return on Tangible Assets |
41.45% | 41.67% | 40.08% | 45.36% | 46.30% | 47.85% | 52.02% | 23.22% | 0.51% | 15.11% |
Average Days of Receivables |
95.58 | 90.48 | 86.69 | 88.78 | 80.27 | 88.47 | 89.14 | 85.72 | 84.38 | 82.41 |
Research and Development Expense of Revenue |
6.18% | 6.19% | 5.92% | 5.93% | 6.04% | 5.95% | 5.94% | 5.93% | 5.74% | 5.78% |
Selling, General and Administrative Expense of Revenue |
26.23% | 23.33% | 24.90% | 22.14% | 22.51% | 23.41% | 22.22% | 22.19% | 23.57% | 23.64% |
Intangible Assets out of Total Assets |
0.37 | 0.41 | 0.42 | 0.20 | 0.22 | 0.25 | 0.23 | 0.16 | 0.11 | 0.12 |
Share Based Compensation of Revenue |
1.71% | 1.51% | 1.25% | 1.43% | 1.07% | 1.56% | 1.60% | 1.55% | 1.71% | 1.89% |
Graham Net Nets |
(0.02) | (0.05) | (0.09) | (0.05) | (0.05) | (0.08) | (0.09) | 0.03 | 0.08 | 0.12 |
Graham Number |
102.24 | 86.38 | 69.07 | 47.29 | 38.91 | 26.57 | 0.00 | 59.54 | 12.30 | 64.41 |
Earnings Yield |
2.84% | 2.90% | 3.31% | 3.42% | 3.02% | 3.39% | 3.79% | 4.10% | 0.12% | 4.74% |
Free Cash Flow Yield |
2.25% | 2.82% | (4.33%) | 2.07% | 2.52% | 3.47% | 3.00% | 3.47% | 3.89% | 4.86% |
Revenue per Share |
53.19 | 49.86 | 50.04 | 49.55 | 45.24 | 38.09 | 35.59 | 31.43 | 28.94 | 26.83 |
Operating CF per Share |
10.97 | 12.84 | 10.20 | 10.20 | 12.14 | 12.73 | 9.51 | 7.85 | 8.74 | 7.96 |
Capex per Share |
(2.44) | (2.40) | (24.43) | (3.06) | (2.73) | (4.07) | (2.42) | (1.25) | (1.13) | (1.13) |
Free Cash Flow per Share |
8.53 | 10.44 | (14.22) | 7.14 | 9.40 | 8.66 | 7.09 | 6.60 | 7.61 | 6.83 |
Cash per Share |
9.88 | 5.48 | 6.70 | 8.03 | 9.25 | 7.14 | 4.99 | 22.54 | 42.53 | 34.82 |
Shareholders Equity per Share |
43.04 | 30.82 | 19.47 | 8.41 | 5.97 | 3.74 | (3.20) | 20.36 | 27.99 | 28.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
43.04 | 30.82 | 19.47 | 8.41 | 5.97 | 3.74 | (3.20) | 20.36 | 27.99 | 28.49 |
Free Cash Flow |
507.60 | 619.64 | (840.18) | 428.21 | 579.01 | 537.58 | 479.26 | 508.37 | 607.17 | 551.95 |
Working Capital |
908.15 | 879.35 | 963.29 | 978.17 | 948.43 | 596.05 | 721.16 | 2,214.23 | 3,663.98 | 3,115.12 |
Capital Expenditures |
(144.96) | (142.48) | (1,442.99) | (183.46) | (168.27) | (252.93) | (163.82) | (96.08) | (90.47) | (90.97) |
Net Current Asset Value |
(367.66) | (1,056.18) | (1,723.65) | (1,013.06) | (1,098.44) | (1,206.74) | (1,460.84) | 503.00 | 1,179.57 | 1,275.34 |
EV/EBIT |
28.61 | 28.21 | 26.08 | 24.93 | 29.07 | 24.98 | 24.06 | 18.84 | 21.32 | 15.86 |
Capex to Sales |
0.05 | 0.05 | 0.49 | 0.06 | 0.06 | 0.11 | 0.07 | 0.04 | 0.04 | 0.04 |
Price to Operating Income |
28.16 | 26.64 | 23.74 | 23.74 | 27.92 | 23.80 | 22.30 | 19.63 | 23.58 | 17.63 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.32 | 0.29 | 0.26 | 0.22 | 0.24 | 0.25 | 0.25 | 0.32 | 0.30 | 0.29 |
Cash ROIC |
12.39% | 16.39% | (21.81%) | 17.05% | 23.63% | 28.57% | 28.16% | 11.42% | 8.07% | 8.10% |
Accounts Receivable Turnover |
4.05 | 4.12 | 4.15 | 4.45 | 4.70 | 4.07 | 4.16 | 4.39 | 4.51 | 4.53 |
Accounts Payable Turnover |
12.65 | 13.00 | 13.43 | 13.13 | 13.69 | 16.61 | 17.25 | 14.96 | 14.32 | 12.89 |
Inventory Turnover |
2.46 | 2.42 | 2.46 | 3.08 | 3.50 | 3.22 | 3.30 | 3.53 | 3.55 | 3.39 |
Average Days of Payables |
29.39 | 30.39 | 25.87 | 27.28 | 30.55 | 26.18 | 17.70 | 25.07 | 24.87 | 27.74 |
Days of Inventory on Hand |
162.10 | 145.14 | 157.65 | 133.26 | 112.38 | 110.32 | 115.76 | 107.22 | 104.17 | 107.55 |
Average Receivables |
781.10 | 717.77 | 712.53 | 667.77 | 592.98 | 580.53 | 578.03 | 551.07 | 511.58 | 478.83 |
Average Payables |
101.85 | 92.32 | 89.00 | 95.05 | 84.51 | 60.61 | 58.58 | 66.35 | 66.14 | 69.16 |
Average Inventory |
524.82 | 496.75 | 485.97 | 405.90 | 330.19 | 312.42 | 306.06 | 280.93 | 266.49 | 263.05 |
Average Assets |
4,815.17 | 4,590.32 | 3,954.15 | 3,188.19 | 2,967.43 | 2,698.49 | 3,142.24 | 4,525.89 | 4,993.21 | 4,465.37 |
Average Common Equity |
2,194.87 | 1,489.42 | 827.41 | 436.02 | 299.85 | 7.93 | 675.49 | 1,900.52 | 2,267.87 | 2,180.40 |
Columns are period end dates